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Abstract 
Periodate oxidation of eight N6-substituted adenosine derivatives was performed with the aim of oxidizing the vicinal 2' and 3' 
hydroxyl groups of the ribose moiety. A thermodynamical and pharmacological characterization f the products of this transformation 
allowed us to verify that o:~idized adenosine analogues act as agonists at adenosine A~ receptors. The dependence of their association 
constants on temperature indicates that their binding is entropy driven, a feature typical of adenosine A I receptor agonists; moreover all 
synthesized compounds were able to fully inhibit the forskolin induced c-AMP accumulation i rat isolated adipocytes. This is the first 
report suggesting that the presence of an intact ribose moiety is not necessary for agonistic activity at adenosine A~ receptor. In fact 
periodate oxidation of the ribose moiety yields a dialdehyde and it is recognized that nucleoside dialdehydes are complex equilibrium 
mixtures of cyclic and acyclic hydrates and hemiacetals. 
1. Introduction 
Adenosine modulates a great variety of biological func- 
tions both in the nervous system and in pheripheral tissues 
[1]. Most of its effects appear to be mediated via two 
subtypes of specific membrane receptors, termed A~ and 
A ~, which inhibit or stimulate, respectively, the adenylyl 
cyclase activity with consequent decrease or increase of 
the intracellular levels of the second messenger 3'-5'-cyclic 
adenosine monophosphate (c-AMP) [2,3]. More recently 
adenosine A s receptors have been divided into A2a (high 
affinity) and A2b (low affinity) subtypes and evidence for 
the existence of an A 3 receptor subtype has been raised 
[4]. 
Adenosine receptor agonists are closely related chemi- 
cally to the endogenous', ligand adenosine. Except for a 
limited number of modifications at the 5' position, the 
intact ribose moiety seems to be an essential fragment for 
agonistic activity. Some adenine derivatives which lack the 
ribose moiety, such as 9-methyladenosine [5] and 9- 
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phenyl-7-deazadenine [6] derivatives, are adenosine antag- 
onists. 
The structural requirements for the ribose moiety appear 
to be very strict: opening or enlargement of the pentose 
ring to a hexose ring are detrimental for affinity, as is 
inversion of the stereochemistry of the 5'-hydroxymethyl 
group [7]. The presence of a hydroxyl group on the 2' 
position is essential for high affinity and high intrinsic 
activity. Removal of the hydroxyl groups at either the 3' or 
the 5' positions yields partial agonists that still have con- 
siderable affinity [7]. The 2',3'-dideoxy analogue of CHA 
has been reported to act as a weak antagonist [8]. Recently, 
the 2'-deoxy and 3'-deoxy analogues of adenosine and 
N6-substituted analogues have been proposed as partial 
agonists for the adenosine receptor [9] and the compound 
6-cyclohexyl-2'-O-methyladenosine has been described as 
a potent and selective adenosine A 1 receptor agonist [10]. 
Binding thermodynamic analysis of adenosine agonists 
and xanthine antagonists at adenosine A 1 receptor evealed 
an entropy-driven binding of agonists and an enthalpy- 
driven binding of antagonists [11-13]. These data allowed 
to hypothesize a model of the adenosine A 1 receptor where 
the ribose moiety can replace and destroy a network of 
water molecules connecting two different domains of the 
146 A. Dalpiaz et al./ Biochimica et Biophysica Acta 1267 (1995) 145-151 
A~ receptor. According to this model the release of solvent 
molecules and the insertion of the ribose moiety would 
cause receptor conformation changes producing the final 
effect [13,14]. 
Ribose modification of 2'-3' hydroxilic groups by 
sodium periodate has been instrumental in obtaining reac- 
tive nucleotides and nucleosides [ 15,16]. 
This paper deals with the pharmacological nd bio- 
chemical characterization f compounds obtained after pe- 
riodate oxidation of N6-substituted adenosine derivatives 
which retain agonistic activity at the A~ receptor. The 
agonistic behaviour of these modifidied ribose compounds, 
the first ever reported without an intact ribose ring, has 
been determined by measuring their capability to inhibit 
the forskolin-stimulated 3'-5' cyclic adenosine monophos- 
phate (c-AMP) accumulation in isolated epididymal rat 
adipocytes after stimulation by forskolin and will be dis- 
cussed from a thermodynamical point of view. 
2. Materials and methods 
2.1. Materials 
N6-[3H]Cyclohexyladenosine ([3H]CHA: specific activ- 
ity = 30.2 Ci/mmol) and Aquassure were obtained from 
NEN, Du pont de Nemours Italiana, (Milano, Italy). N 6- 
Cyclohexyladenosine (CHA), N6-cyclopentyladenosine 
(CPA), N6-R-phenylisopropyladenosine (R-PIA), N6-S  - 
phenylisopropyladenosine (S-PIA), N6-phenyladenosine 
(PhADO), N6-benzyladenosine (BzADO), N6-phenyleth - 
yladenosine (PhEtADO), N6-methyladenosine (MeADO) 
and 1,3-dipropyl-8-cyclopentylxantine (DPCPX) were pur- 
chased from Sigma, St. Louis, MO. Male Wistar rats were 
acquired from Nossan Laboratories (Varese, Italy). Bovine 
serum albumin (fraction V), forskolin, adenosine deami- 
nase (type VI), aminophylline, 3'-5'-cyclic monophosphate 
(c-AMP) and collagenase (type II) were obtained from 
Sigma (St. Louis, MO, USA). Ro 20-1724 (4-(3-butoxy- 
4-methoxybenzyl)-2-imidazolidinone) was a kind gift of 
Dr. E. Kyburz, Hoffmann-La Roche (Basel, Switzerland). 
[3H]c-AMP (specific activity=24 Ci/mmol) was ob- 
tained from Amersham (Milano, Italy). Ready Gel was 
obtained from Beckman (Irvine, CA, USA). 
Unless otherwise stated, other materials were from stan- 
dard sources. 
2.2. Synthesis of oxidized adenosine analogues 
Synthetic procedure was performed to obtain 
periodate-oxidized derivatives of CHA (CHAox), CPA 
(CPAox), R-PIA (R-PIAox), S-PIA (S-PIAox), PhADO 
(PhADOox) ,  BzADO (BzADOox) ,  PhEtADO 
(PhEtADOox) and MeADO (MeADOox). Oxidized adeno- 
sine analogues preparation was carried out essentially as 
described by Gilham [17]: 1 mM N6-substituted a enosine 
analogues and 1 mM metaperiodate cold solutions in wa- 
ter, pH 6.0, were mixed together and the reaction was 
allowed to proceed for 1 h at 0 ° C in the dark. The reaction 
was monitored by thin-layer chromatography on silica with 
methanol/chloroform (1:9) as developing solvent. Iodate 
was removed by filtration through Sep-Pak Cartridge, the 
oxidized product was eluted with acetonitrile and the 
solvent was evaporated to dryness. 
To confirm the purity of the oxidized products, N6-sub  - 
stituted adenosine nucleotides and the corresponding ri- 
bosil oxidized derivatives were analyzed at room tempera- 
ture by HPLC. A Beckman high pressure liquid chromato- 
graph (Sistem Gold programmable Solvent Module 126) 
and a Beckman ODS (4.6 mm × 25 cm) column were 
used. During the first 4 rain, (flow rate 1 ml/min) water 
was used as solvent, than a linear water-methanol gradient 
at a constant flow rate was used for the evaluation of the 
retention times of nucleosides and oxidized analogues. All 
compounds were injected as their hydrochloride salts dis- 
solved in aqueous olution at concentrations of approx. 0.4 
mg/ml. 100 #1 aliquots were applied to column chro- 
matography. 
Spectral properties of adenosine dialdehyde were as- 
signed by IR and NMR measurements. IR spectra were 
taken on paraffin oil mulls on a Perkin-EImer Model 1310 
instrument. [IH]NMR spectra were detected with a Varian 
CFT-20 instrument operating at 80 MHz in a 2% D20 
solution, using Me4Si as the internal standard. 
2.3. Membrane preparation 
Male Wistar rats (150-200 g) were decapitated and the 
whole brain (minus brainstem, striatum and cerebellum) 
was dissected on ice. The tissue was disrupted in a Poly- 
tron (setting 5) in 20 vols of 50 mM Tris-HCl, pH 7.4. The 
homogenate was centrifuged at 48 000 × g for 10 min and 
the pellet was resuspended in the same buffer, centrifuged 
and resuspended in Tris-HCl containing 2 IU/ml adeno- 
sine deaminase (type VI). After 30 min incubation at 37 ° C 
the membranes were centrifuged and pellets were stored at 
-70  ° C. Prior to freezing, an aliquot of homogenate was 
removed for protein assay [18]. 
2.4. Preparation of rat adipocytes 
Isolated rat fat cells were prepared essentially according 
to the method of Rodbell [19]. Wistar male rats (250-300 
g) were killed by decapitation. The epididymal fat pads 
were quickly removed, washed in physiological solution 
and immediately placed in a beaker with a Krebs-Ringer 
bicarbonate buffer containing NaCI 125 mM, KCI 5 mM, 
CaC12 1 mM, KHzPO 4 1 mM, MgSO4.7H20 1.2 mM, 
glucose 0.1%, 1% bovine serum albumin (fraction V), 
gassed with 5% CO 2 and 95% 0 2. The pads were cut in 
small pieces and transferred, with buffer, into a plastic 
beaker containing 1 mg/ml of collagenase (type II). The 
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mixture was incubated for 45 min at 37°C in a shaking 
bath. The contents were filtered twice through a nylon 
sieve to remove undigested tissue. Adipocytes were then 
washed two or three times with buffer and then centrifuged 
at 100 X g for 15 s. Finally diluted aliquots of fat cells 
were counted under an optical microscope. 
2.5. Receptor  binding assays 
Binding assays were performed at 0, 10, 20 and 25°C 
essentially according to Bruns et al. [20]. Displacement 
experiments were performed in 1 ml of buffer containing 1 
nM [3H]CHA and membranes from 15 mg (wet weight) of 
tissue. To determine IC:s 0 values (where ICs0 is the in- 
hibitor concentration displacing 50% of the labelled lig- 
and), fresh solutions of the test compounds were added in 
triplicate to the binding assay samples at a minimum of six 
different concentrations. Saturation binding experiments 
were carried out using 8 to 12 concentrations of [3H]CHA 
ranging from 0.1 to 10 nM. Separation of bound from free 
radioligand was performed by rapid filtration through 
Whatman GF/B  filters which were washed three times 
with ice-cold buffer. Filler bound radioactivity was mea- 
sured by scintillation spectrometry after addition of 4 ml of 
Aquassure. Non-specific binding was defined as the bind- 
ing in presence of 10 /xM (R)-N6-phenylisopropyl adeno- 
sine (R-PIA); this is always < 10% of the total binding. 
The incubation time ranged from 2.5 h at 0°C to 1.75 at 
25°C according to the results of previous time course 
experiments. K~ values were calculated from the Cheng 
and Prusoff equation [2111. All binding data were analysed 
using the non-linear egression curve fitting computer pro- 
gram LIGAND [22]. 
2.6. Calculat ions 
For a generic binding equilibrium L + R = LR (L  = 
Ligand, R = Receptor), the affinity constant is calculated 
as K a = [LR]/([L][R]) =: [LR]/([Lma × - tR][Oma x - LR]) 
= I lK  a, where [Lr, ax] = total concentration of the ligand 
added, [B,nax ] = total concentration of the binding sites and 
K a = dissociation constant. As [LR]/[Lm~  -LR]  = 
[Bound]/[Free] = [Bm~x]K ~ -Ka[Bound], the Ka and Bma x 
values can be obtained from the slope and intercept of the 
Scatchard plot [Bound]/[Free] versus [Bound]. The stan- 
dard free energy was calculated as AG ° = -RT  In K, at 
298.15 K, the standard enthalpy, AH °, from the van 
t'Hoff plot In K~ versus (1 /T )  (whose slope is -AH° /R)  
and the standard entropy :as AS ° = ( AH ° - AG°) /T  with 
T= 298.15 K and R = 8.314 J /K  per mol. 
inhibitor and incubated for l0 min at 37°C in a shaking 
bath. Then adenosine A~ receptor agonists and forskolin at 
1 /zM final concentration were added and, after a 5 rain 
time of incubation, the reaction was stopped by adding 
ice-cold 6% (w/v,  final concentration) of trichloroacetic 
acid. Trichloroacetic acid suspensions were centrifuged at 
2000 × g for 10 min at 4 ° C and the acidic supematant was 
extracted four times with water-saturated thyl ether. The 
final aqueous olution was tested for c-AMP by a competi- 
tive protein binding assay carried out essentially according 
to Brown et al. [23] and Nordstet and Fredholm [24]. The 
sample (100 /zl) or 50 /xl c-AMP standard (0-10 pmol) 
was added at each test tube containing Trizma base 100 
/zM, aminophylline 8 mM, 2-mercaptoethanol 6 mM at pH 
7.4. 
[3H]c-AMP (1 pmol, approx. 25 000 cpm) was added to 
each tube at a total assay volume of 500 /zl. Binding 
protein, previously prepared from beef adrenals essentially 
according to Brown et al. [23], was added to the samples. 
They were incubated at 4 ° C for 150 rain and, after the 
addition of albumin saturated charcoal, centrifuged at 2000 
× g for 10 rain. 200 p.l aliquots of clear supernatant were 
mixed with 4 ml of Ready Gel and counted in a Beckman 
liquid scintillation spectrometer (Beckmann LS 1800 
Irvine, CA, USA) at a counting efficiency of about 55%. 
Results were expressed as pmol of c-AMP per l05 
adipocytes. 
ICso values in the c-AMP assays were obtained for 
fresh solutions of the compound under examination from 
the concentration-inhibition curves by linear regression 
after logit-log transformation. 
3. Results 
All selected N6-substituted adenosine dialdehydes, 
which were prepared as potential adenosine A l receptor 
competitive ligands, were obtained by oxidation of the 
corresponding ribonucleosides u ing 1 equivalent of sodium 
metaperiodate in H20 (Scheme 1). 
NHR NHR 
~'.~N ,.,;-"-~ N" ~N ...,,,~.~ N ~> 
OH OH 
Scheme 1. 
2.7. Determinat ion o f  cycl ic AMP levels 
105 fat cells were suspended in 400 /zl of Krebs-Ringer 
buffer, pH 7.4, containing 1 IU/ml  of adenosine deami- 
nase (type VI), 0.5 mM Ro 20-1724 as phosphodiesterase 
These ribonucleoside dialdehydes were quite unstable 
under the acidic reaction condition (pH 6), therefore, after 
reaction, iodate was removed by filtration through Sep-Pak 
Cartridge, and the oxidized product was eluted with aceto- 
nitrile and the solvent was evaporated to dryness. Usual 
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Table 1 
Inhibitory binding constants at 25 ° C, K i (nM), for the displacement of [3H]CHA from rat brain adenosine A 1 receptors by a selection of adenosine 
agonists and periodate-oxidized analogues 
RNI-I 
FIO s" O. I 
OH OH 
Compound R K i Periodate 
oxidized 
compound 
Ki 
CHA Cyclohexyl 1.0( + 0.03) CHAox 9.0( 4- 0.4) 
CPA Cyclopenthyl 0.03( 4- 0.001 ) CPAox 1.03( 4- 0.06) 
R-PIA Phenylisoproyl 0.60( 4- 0.03) R-PIAox 6.2( 4- 0.3) 
S-PIA Phenylisopropyl 11.7( + 0.9) S-PIAox 300( 4- 18) 
PhADO Phenyl 4.1( + 0.3) PhADOox 38( ± 3) 
PhEtADO Phenylethyl 11.5( 4- 0.9) PhEtADOox 100( _+ 9) 
BzADO Benzyl 57.9( 4. 4) BzADOox 930( 4. 47) 
MeADO Methyl 126( + 11) MeADOox 1,540( 4- 76) 
Values are means (4. S.E.) of four separate experiments. 
crystallization and characterization by chemical analysis 
were prohibited by the low amounts of the compounds. In 
an effort to ensure the absence of the starting material in 
miscellaneous with oxidized product, we performed a 
chromatographic haracterization of the N6-substituted 
adenosine nucleosides and the corresponding oxidized ana- 
logues. All selected compounds, before and after oxidation 
demonstrated a single spot at TLC analysis and a single 
peak at HPLC analysis, carried out as described in Section 
2. Retention Factor values, (TLC) and Retention Time 
values, (HPLC) were different for tested adenosine ana- 
logues before and after oxidation (data not shown). Chro- 
matographic properties of all oxidized compounds re- 
mained unchanged when the dried products were stored at 
5 ° C at least for 3 months. 
In an effort to elucidate the chemical structure of N 6- 
substituted adenosine dialdehydes in solution, we investi- 
gated the spectral properties (IR and NMR) of adenosine 
dialdehyde, which was obtained by periodate oxidation of 
the corresponding ribonucleoside, as previously reported 
[25]. The oxidized product did not exhibit the expected 
carbonyl stretching vibrations in the IR region (1700 
cm 1), nor did it exhibit free aldehydic protons in the 
NMR (o- 8.5-10.0).  Instead, we observed hydroxyl 
stretching vibrations (3300 cm -1)  in the IR, and the NMR 
showed the C2' and C3' protons upfield in the range of 6 
Table 2 
Equilibrium binding parameters at four different emperatures for the displacement of [3H]CHA from rat brain adenosine A I receptors by eight 
N6-substituted 2',3'-oxo-adenosine derivatives 
Ligand T(K) 273 283 293 298 
T( ° C) 0 10 20 25 
[ 3 H]CHA K d 4.4( _+ 0.2) 1.6( 4. 0.1 ) 1.3( _+ 0.05 ) 1.04( _+ 0.04) 
Bma x 198( + 16) 208( ± 15) 202( + 14) 210( + 12) 
CHAox K~ 48( + 3) 12.6( ± 0.5) 9.8( -I- 0.5) 9.0( + 0.4) 
CPAox K~ 5.4( ± 0.3) 4.1( + 0.2) 2.04( 4- 0.1 ) 1.03( 4- 0.06) 
R-PIAox K~ 17.1( 4- 0.9) 8.8( +_ 0.4) 5.5( _+ 0.3) 6.2( ± 0.3) 
S-PIAox K~ 1460( + 70) 503( 4- 27) 382( 4- 21) 300( 4- 18) 
PhADOox K~ 179( 4- 8) 80( 4- 5) 60( + 4) 38( 4. 3) 
BzADOox K~ 2640( 4. 154) 1380( 4. 75) 1030( + 58) 930( + 47) 
PhEtADOox K~ 447(4.21) 308(_+ 16) 229(4. 11) 100(+9) 
MeADOox K~ 4800( 4- 300) 1800( 4- 94) 1530( _+ 80) 1540( 4. 76) 
Dissociation, Kd, and inhibition, Ki, constants in nM and Brnax in fmol/mg of protein. Values are means + S.E. of four experiments. 
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5.2-6.0. These spectral data suggest hat the dialdehydes 
probably exist in various hydrated forms rather than as free 
aldehydes. 
Scheme 2 reports the possible structures of adenosine 
dialdehyde and related compounds which exist at equilib- 
rium in aqueous olution. 
HO- -~o~den ine  
CHO CHO 
I 
HO- -~o~den ine  
HO--CH HC-OH I I OH OH 
II 
/ 
HO---~/O. adenine 
HO OH 
III 
C•X•,• O adenine 
HO~ :H CIH 
OH OH 
IV 
Scheme 2. 
Possible structures include the hydrated form II and the 
various possible diastereoisomeric forms of hydrated 
species III. The hydrated structure IV is also possible 
because of the additional _';'-hydroxyl group. They exist in 
deuterium oxide as an almost 1:1 mixture of the acyclic 
20 
19 
25' 20" 10" 0" T ('C) 
• CHAox 
~" 16 
~: PhADOox 
15 
PhEtADOox 
13 MeADOox 
12 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  , . . . . . . . . . . . . . . . . . .  I 
3.3 3.4 3.5 3.5 3.7 3.8 3.9 
1 /T  (1000/K I  
Fig. 1. Representative an't Hoff plots showing the effect of temperature 
on the equilibrium association constants, K a, for a selection of four 
oxidized adenosine derivatives. All plots are essentially linear ( r  > 0.96) 
in the temperature ange from 0 ° C to 25 ° C. 
hydratated ialdehyde (II) and the hemiacetal (III, IV) 
form. 
All selected compounds were evaluated for A~ adeno- 
sine receptor affinity as measured by the ability to displace 
1 nM [3H]CHA from rat brain adenosine A~ receptors at 
25 ° C. The results are shown in Table 1. For each of the 
oxidized adenosine derivatives tested, at the chosen tem- 
peratures, K i values were systematically greater than those 
of the equivalent N6-monosubstituted analogues which 
have been previously reported in [13]. 
Table 2 reports the values of inhibitory binding con- 
stant, K~, obtained at the four chosen temperatures for the 
selected eight ligands; Ka and Bma x values, derived from 
saturation experiments carried out with [3H]CHA in the 
range 0.1-10 nM, are also shown. Since K i values can be 
considered equivalent to the dissociation equilibrium con- 
stants, K a, the K d value measured for [3H]CHA can be 
considered to be homogenous with the other tabulated 
data. Bma x values obtained from saturation experiments 
appear to be largely independent of temperature, at vari- 
ance with inhibitory binding constants which change with 
Table 3 
Thermodynamic parameters for displacement of [3H]CHA, by N6-substituted 2',3'-oxo-adenosine d rivatives, from rat brain adenosine A 1 receptors and 
IC50 values in the c-AMP assays obtained from the concentration-response curves by linear regression analysis after logit-log transformation 
Compound zIG ° AH ° AS ° IC50 (riM) 
(k J /mol )  (k J /mol )  ( J /mol  per K) c-AMP assay 
CHAox -46 .3  _+ 0.3 42 + 10 297 + 38 8.1 + 0.7 
CPAox -51 .7  _+ 0.3 44 + 9 320 + 32 0.23 + 0.01 
R-PIAox -47 .6  _+ 0.3 30 + 6 259 + 23 2.2 + 0.1 
S-PIAox - 37.2 _+ 0.3 40 + 8 260 + 29 11 + 1 
PhADOox -42 .0  + 0.2 39 + 5 271 _ 18 1.5 + 0.2 
BzADOox -34 .5  + 0.2 28 + 4 210 + 13 2000 + 150 
PhEtADOox - 39.9 _ 0.3 35 + 10 249 _ 36 510 _ 48 
MeADOox - 33.5 _+_ 0.3 29 + 10 210 4- 34 3000 + 280 
Values are means _ S.E. of four separate xperiments. 
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changing temperature. The temperature dependence of 
affinity constants, K a = I/K~, is exemplified by the van't 
Hoff plots In K~ versus I / T  of Fig. 1, reporting typical 
results for four compounds (CHAox, PhADOox, PhEtA- 
DOox, MeADOox). Van't Hoff plots appear to be essen- 
tially linear in the range 0-25°C for all selected com- 
pounds. The linearity of the van't Hoff plots indicates that 
AC~, is nearly zero seemingly a general property of most 
classical membrane receptor so far studied [26]. The slopes 
of the van't Hoff plots are consistently positive for the 
selected compounds whose affinities are improved by a 
temperature increase (Fig. 1). Final thermodynamic param- 
eters calculated for the binding equilibria of the different 
compounds investigated are reported in Table 3. AG ° 
values range fi'om -51.7 to -33.5 kJ mol-~, while 
equilibrium standard values of enthalpy, AH °, and of 
entropy, AS ° show that the binding of the selected com- 
pounds is totally entropy-driven (28 < AH ° < 44 kJ tool- l; 
210 < AS" < 278 J mol ~ K 1). Referring to the thermo- 
dynamic discrimination between adenosine agonists and 
xanthine antagonists [11-13], the entropy-driven binding 
of the oxidized derivatives indicates that their mechanism 
of interaction with adenosine A ~ receptor is similar to that 
of adenosine analogues, thus suggesting an agonist be- 
haviour. These indications are confirmed by the capability 
of all oxidized adenosine derivatives to fully inhibit the 
forskolin induced c-AMP accumulation in rat isolated 
adipocytes. The inhibition was fully blocked by the spe- 
cific adenosine A~ receptor antagonist, DPCPX, which 
proves an adenosine A~ receptor mediated effect. The ICs0 
values in the c-AMP assay, reported in Table 3, are 
obtained from the concentration-response curves, reported 
in Fig. 2, by linear regression analysis after logit-log 
transformation a d range from 0.23 nM to 3000 nM. 
10o 
° ~  o 
o~ 80 o 
'~ 6() 
% 40 
~ 20 
" o . . . . . . . .  I , @ , , , 
11 10 g 8 7 6 S 4 3 
- Log DRUG CONCENTRATION (M) 
Fig. 2. Inhibition of forskolin-stimulated c-AMP levels in rat isolated 
adipocytes by oxidized adenosine derivatives (O, CHAox; B, CPAox; 
• ,, R-PIAox; O, S-PIAox; C), PhADOox; D, BzADOox; zx, PhEtA- 
DOox; ~, MeADOox). This is a single representative experiment carried 
out in duplicate. 
4. Discussion 
The data accumulated in the literature on molecular 
modifications of adenosine structure indicate the physio- 
logical activity mediated by specific receptors to be limited 
largely to analogues with intact purine ring and /3- 
ribofuranosyl moieties. The adenine moiety is reported as 
being more amenable to substitutions than the ribose moi- 
ety. A number of useful modifications may be performed 
at C 2 and N 6 amino group [27-29]. In particular Nr-sub -
stituted analogues of adenosine have generally proven to 
be A~-receptor selective with N6-cyclohexyladenosine 
(CHA) being 400-800 fold selective [30]. 
Furthermore, according to reports in the literature, few 
alterations of the ribose moiety are tolerated at the adeno- 
sine receptor binding site [5]. The 5' position can be 
modified to some extent to yield compounds that retain 
high affinity. The best known examples are 5'-(N- 
ethyl)carboxamidoadenosine (NECA), 2-hexynyl-5'-(N- 
ethyl) carboxamidoadenosine (HE-NECA) and 2-[p- 
(carboxyethyl)-phenethylamino]-5'-(N-ethyl) carboxami- 
doadenosine (CGS 21680), all containing a 5'-N-ethyl- 
carboxamido group. The modification at N 9 include deoxy 
sugars, 5'-substituted-5'-deoxyriboses, non-ribose sugars, 
sugar ring homologues, and acyclic sugar analogues hav- 
ing poor affinity for adenosine receptors. Only minor 
modifications at 3' position maintain potent binding [7]. 
However, the present paper demonstrates that the perio- 
date oxidation of Nr-substituted adenosine derivatives al- 
lows maintenance of a specificity and a typical agonistic 
behaviour similar to that of the parent compounds which 
has been characterized by an entropy driven binding [11- 
13] and by the capability to inhibit the forskolin induced 
c-AMP accumulation in rat isolated adipocytes. The en- 
tropy-driven binding associated to the agonistic behaviour 
can be explained by hypothesizing the substitution from 
the binding site of a network of water molecules with a 
bulky hydrophilic fragment: the ribose moiety, in the case 
of adenosine derivatives [13,14], and by a fragment differ- 
ent from ribose after periodate oxidation. This is the first 
report about the existence of adenosine A j agonists lack- 
ing an intact ribose linked to the nitrogen at position 9 of 
the adenosine pyrimidine nucleus. Some considerations are 
in order regarding the characterization of the fragment 
derived after the periodate oxidation of the ribose moiety. 
In fact oxidation of single glycosides such as methyl 
O~-D-glucopyranoside with sodium metaperiodate yields a 
dialdehyde [31,32]. However, it is well documented that 
after solubilization ucleoside dialdehydes are capable to 
exist in a variety of modifications, depending on such 
conditions as the type of solvent [25]. In water or buffer 
they may exist as complex equilibrium mixtures of cyclic 
and acyclic hydrates and hemiacetals [25]. However, since 
crude product did not display absorption in the infrared 
region of the spectrum characteristic of aldehyde groups, it 
seems probable that the products exist as various acetals. 
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These results are confirmed by the generally recognized 
fact that nucleoside dialdehydes are really complex equi- 
librium mixtures of cyclic and acyclic hydrates and hemi- 
acetals, as previously repo:rted [33-35]. 
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